Newsroom / Remote Patient Monitoring

In the US, use of the Mitra device with blood is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device is approved as a remote blood sample collection device for some clinical applications, as referenced in some of the news content posted here.

Neoteryx Expands European Footprint with Opening of Neoteryx B.V.

by Neoteryx, on January 21,2019

Neoteryx Expands European Footprint with Opening of Neoteryx B.V.

With significant worldwide growth in demand for microsampling technology, Neoteryx is opening new offices! We're expanding our European operations to better meet the needs of both new and existing customers …

Read Story
Topics:

Neoteryx LLC and Cedars-Sinai Partner to Investigate At-Home Blood Sampling Possibilities for Patients with Inflammatory Bowel Disease

by Neoteryx, on August 16,2018

Neoteryx LLC and Cedars-Sinai Partner to Investigate At-Home Blood Sampling Possibilities for Patients with Inflammatory Bowel Disease

At-home blood sampling provides convenience and cost savings to patients. TORRANCE, California (August 16, 2018) – Neoteryx LLC, inventor of Volumetric Absorptive Microsampling (VAMS™) technology, has signed a research agreement …

Read Story
Topics:
Prev All Posts Next

The latest product releases, company news and microsampling industry updates from Neoteryx.

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs
Neoteryx Experts

Media Contacts
Media Assets
Scientific Research Publications

social media

subscribe to news

Fuel Your Innovative Approach to Science & Research. Subscribe to Our Microsampling Newsletter!

Get Our Newsletter

 

Get in Touch

 

Neoteryx, LLC

© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501

This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.

Get To Know Us

Follow Us

Mitra® is an exempt medical device in the US, CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, and registered with Health Canada. It is intended as a specimen collector and for the storage and transport of biological fluids. Use of the device with blood for diagnostic applications is limited to certain countries and, in the US, for research and non-diagnostic purposes only. Neoteryx Products are not marketed in the US for clinical diagnostic uses. In other countries, Neoteryx Products may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Neoteryx operates a Quality Management System (QMS) that is based on FDA good manufacturing practices, 21 CFR 820 regulations, and ISO-13485.

Copyright © 2020 Neoteryx, LLC. All rights reserved.